Patient dosing has begun in a phase 1 trial evaluating QXL138AM, a masked immunocytokine targeting CD138, in advanced solid ...

Although rare, some may experience longer-term ones, such as arm or shoulder pain, lung scarring, weakened bones, and ...

Cyrus M. Khan, MD, discussed recent advancements in CLL treatment, particularly the shift to nonchemotherapy options and the ...

To try and find out, they reviewed routinely collected and linked primary and secondary care health data for adults in ...

Key outcomes included: Agreement on Phase 3 study design, including the standard-of-care control arm and the primary and secondary study endpoints ... in 2024 or early 2025 under the auspices of the ...

For more information about Cellectar, please visit Cellectar.com. To learn more about SpectronRx, visit SpectronRx.com.

Researchers at the Center for Genomic Regulation (CRG) reveal that metabolic enzymes known for their roles in energy ...

An exhibition of secondary breast cancer patients is raising awareness at a Guildford centre A photography exhibition of secondary breast cancer patients is aiming to raise awareness of the signs ...

A photography exhibition of secondary breast cancer patients is aiming to raise awareness of the signs of metastasis. Photographer Abigail Fahey, from Worthing in West Sussex, has captured images ...

CSCs are believed to be the primary cause of drug resistance ... 2024). Currently, advanced secondary cancers are typically only detected after multiple metastases have already occurred. The ...

Receiving radiation therapy for breast cancers harboring TP53 germline variants may cause secondary cancers, but risk estimates are unconfirmed. Patients with breast cancer who carry TP53 germline ...